FDA Plans Crackdown on Online Drug Sales

Publication
Article
OncologyONCOLOGY Vol 13 No 9
Volume 13
Issue 9

Jane Henney, MD, commissioner of the FDA, says that the agency is going to crack down on Internet sales of unapproved new drugs, health fraud (eg, where a site claims some drug will cure cancer), and drugs sold without a valid prescription.

Jane Henney, MD, commissioner of the FDA, says that the agency is going to crack down on Internet sales of unapproved new drugs, health fraud (eg, where a site claims some drug will cure cancer), and drugs sold without a valid prescription. Oftentimes, all customers have to do is fill out an online form, which results in their getting a prescription from a physician who is on the payroll of the website. The problem is that such prescriptions are not illegal per se. Although state medical practice laws frown on physicians prescribing a medication without physically examining a patient, the practice is not illegal. Nor do any states have separate Internet prescribing laws. Henney is particularly concerned about sites that offer quack cures for cancer.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
2 experts in this video
Related Content